Two Top Stocks To Ponder On: OUTFRONT Media Inc. (NYSE:OUT), Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

OUTFRONT Media Inc. (NYSE:OUT)

OUTFRONT Media Inc. (NYSE:OUT) closed at $14.6 on the last trading session with an increase of 3.91%, whereas, it previously closed at $14.05. The company has a market capitalization of $2.18 Billion. The company traded shares of 1.57 Million on the trading day while its three month average volume stands at 2.79 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of OUTFRONT Media Inc. (NYSE:OUT) produced diluted EPS of 0.96. The EPS estimate for next year as estimated by analysts is at 0.66 while EPS for next quarter is estimated at -0.37. Earnings per Share growth for this year is reported at 24.9, while the analysts estimated the EPS growth for next year at 0.66% and Earnings growth for next 5 years stands at 6.7% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -18.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of OUTFRONT Media Inc. (NYSE:OUT) is at 15.19 while the forward p/e is at 22.22. The P/S or Price to Sales ratio of OUTFRONT Media Inc. (NYSE:OUT) stands at 1.21 and Price to Book or P/B for the most recent quarter stands at 2.04. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of OUTFRONT Media Inc. (NYSE:OUT) are reported at 1.2 and 1.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for OUTFRONT Media Inc. (NYSE:OUT) stands at 2.5, 12.8 and 7.7 respectively

The trailing twelve month Revenue of OUTFRONT Media Inc. (NYSE:OUT) is reported at 1.8 Billion with income of 138.3 Million. The outstanding shares of OUTFRONT Media Inc. (NYSE:OUT) are 143.9 Million. The institutional Ownership of the shares of 98.3 stands at 0.80%, this figure is increased 2.73 in the last six months. The insider ownership for the shares of OUTFRONT Media Inc. (NYSE:OUT) is ticked at 0.7%, the figure is plummeted -6.7% in the last six months.

Some other important financial aspects to be discussed here for OUTFRONT Media Inc. (NYSE:OUT) is the Mean Target Price estimated by the analysts which stands at 17.07. The 52 week high of OUTFRONT Media Inc. (NYSE:OUT) is placed at 31.20 and 52 week low is standing at 7.07.

Performance wise the shares of OUTFRONT Media Inc. (NYSE:OUT) fell down -7.42% for the week, it also rise 3.99% for the monthly performance, while for the quarter it went down 13.71%. The shares decrease -45.46% for the half year and plummeted for the Year-To-Date performance. The shares of OUTFRONT Media Inc. (NYSE:OUT) shrinked -43.39% for the yearly performance.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) closed at $109.58 on the last trading session with an increase of 1.52%, whereas, it previously closed at $107.94. The company has a market capitalization of $6.19 Billion. The company traded shares of 515520 on the trading day while its three month average volume stands at 677.7 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) produced diluted EPS of 4.81. The EPS estimate for next year as estimated by analysts is at 16.58 while EPS for next quarter is estimated at 3.19. Earnings per Share growth for this year is reported at 24.5, while the analysts estimated the EPS growth for next year at 16.58% and Earnings growth for next 5 years stands at 4.4% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 57.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is at 22.77 while the forward p/e is at 6.61. The P/S or Price to Sales ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 2.83 and Price to Book or P/B for the most recent quarter stands at 2.18. The Price to Free Cash Flow ratio or P/FCF is reported at 7.64. The quick ratio and the current ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are reported at 3.6 and 3.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 5.2, 9.4 and 12.8 respectively

The trailing twelve month Revenue of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is reported at 2.19 Billion with income of 280.3 Million. The outstanding shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are 55.96 Million. The institutional Ownership of the shares of 95.2 stands at 0.80%, this figure is decreased -3.26 in the last six months. The insider ownership for the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is ticked at 3%, the figure is rose 2.42% in the last six months.

Some other important financial aspects to be discussed here for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is the Mean Target Price estimated by the analysts which stands at 154.69. The 52 week high of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is placed at 154.24 and 52 week low is standing at 86.88.

Performance wise the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) fell down -2.88% for the week, it also fell -8.16% for the monthly performance, while for the quarter it went down 10.02%. The shares decrease -27.4% for the half year and plummeted for the Year-To-Date performance. The shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) shrinked -23.13% for the yearly performance.